Schiffl H - Search Results

1

Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.

Schiffl H. Schiffl H. Eur J Med Res. 2007 Jan 31;12(1):26-33. Eur J Med Res. 2007. PMID: 17363355 Clinical Trial.

2

Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.

Sitter T, Spannagl M, Schiffl H. Sitter T, et al. Among authors: schiffl h. Ann Hematol. 1992 Aug;65(2):79-82. doi: 10.1007/BF01698134. Ann Hematol. 1992. PMID: 1511061

3

Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin.

Schiffl H. Schiffl H. Int J Artif Organs. 1992 Jun;15(6):343-8. Int J Artif Organs. 1992. PMID: 1639525

4

Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients.

Bechtel U, Mücke C, Feucht HE, Schiffl H, Sitter T, Held E. Bechtel U, et al. Among authors: schiffl h. Am J Kidney Dis. 1995 Feb;25(2):291-6. doi: 10.1016/0272-6386(95)90011-x. Am J Kidney Dis. 1995. PMID: 7847357

5

High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.

Küchle C, Fricke H, Held E, Schiffl H. Küchle C, et al. Among authors: schiffl h. Am J Nephrol. 1996;16(6):484-8. doi: 10.1159/000169048. Am J Nephrol. 1996. PMID: 8955759 Clinical Trial.

6

Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calcium.

Schiffl H, Lang SM. Schiffl H, et al. Eur J Med Res. 1997 Mar 24;2(3):97-100. Eur J Med Res. 1997. PMID: 9113497

7

Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis.

Hartmann J, Fricke H, Schiffl H. Hartmann J, et al. Among authors: schiffl h. Am J Kidney Dis. 1997 Sep;30(3):366-73. doi: 10.1016/s0272-6386(97)90281-x. Am J Kidney Dis. 1997. PMID: 9292565 Clinical Trial.

8

Bioincompatibility of dialyzer membranes may have a negative impact on outcome of acute renal failure, independent of the dose of dialysis delivered: a retrospective multicenter analysis.

Schiffl H, Lang SM, Haider M. Schiffl H, et al. ASAIO J. 1998 Sep-Oct;44(5):M418-22. doi: 10.1097/00002480-199809000-00019. ASAIO J. 1998. PMID: 9804464

9

Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.

Schiffl H, Fischer R, Lang SM, Mangel E. Schiffl H, et al. Nephrol Dial Transplant. 2000 Jun;15(6):840-5. doi: 10.1093/ndt/15.6.840. Nephrol Dial Transplant. 2000. PMID: 10831638

10

Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients.

Sitter T, Bergner A, Schiffl H. Sitter T, et al. Among authors: schiffl h. Nephrol Dial Transplant. 2000 Aug;15(8):1207-11. doi: 10.1093/ndt/15.8.1207. Nephrol Dial Transplant. 2000. PMID: 10910446 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results